Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Hisse Senetlerindeki Sıralama #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Hisse Fiyatı
$1.51
Son senkronizasyon: 2024-08-26
Piyasa Değeri
$1.12M
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Agile Therapeutics, Inc. (AGRX)

Kategori

Agile Therapeutics, Inc. (AGRX) için P/B oranı
August 2026 itibarıyla P/B oranı TTM: -0.20
Agile Therapeutics, Inc. şirketinin en son mali raporları ve hisse fiyatına göre, mevcut P/B oranı (TTM) -0.20'dir. 2022 yılının sonunda şirketin P/B oranı -0.88 idi.
Agile Therapeutics, Inc. için P/B oranı geçmişi 2012 - 2026 arası
Her yılın sonunda P/B oranı
Yıl P/B Oranı Değiştir
2026 (TTM) -0.20 -23.23%
2023 -0.26 -70.87%
2022 -0.88 -792.80%
2021 0.13 -97.41%
2020 4.93 82.38%
2019 2.70 175.75%
2018 0.98 -57.24%
2017 2.29 -39.87%
2016 3.81 -47.25%
2015 7.22 271.82%
2014 1.94 -377.53%
2013 -0.70 -17.96%
2012 -0.85 0.00%
Benzer şirketler veya rakipler için P/B oranı